A first update on mapping the human genetic architecture of COVID-19 | Nature
Swiss strike deal for COVAX to get 1 mln Moderna doses more quickly | Reuters
Life | Free Full-Text | Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience
Life | Free Full-Text | The Three Pillars of COVID-19 Convalescent Plasma Therapy
COVID-19 diagnosis by routine blood tests using machine learning | Scientific Reports
In COVID-19 hangover, as more around world get vaccinated, fewer give blood | Reuters
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity - The Lancet Respiratory Medicine
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA) - eClinicalMedicine
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis - The Lancet Microbe
Europe vs. the U.S. - The New York Times
Frontiers | Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
Autoantibodies against type I IFNs in patients with life-threatening COVID-19 | Science
Swiss to keep COVID shots free in 2023 | Reuters
JCM | Free Full-Text | Comparative Clinical Characteristics, Laboratory Findings, and Outcomes of Hypoxemic and Non-Hypoxemic Patients Treated at a Makeshift COVID-19 Unit in Bangladesh: A Retrospective Chart Analysis
Swiss halve quarantine period to five days to cope with Omicron surge | Reuters
COVID | Free Full-Text | Association of ABO Blood Type with Infection and Severity of COVID-19 in Inpatient and Longitudinal Cohorts
Paper-Based Biosensors for COVID-19: A Review of Innovative Tools for Controlling the Pandemic | ACS Omega
Frontiers | COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants - ScienceDirect
JCM | Free Full-Text | Direct Comparison of Clinical Characteristics, Outcomes, and Risk Prediction in Patients with COVID-19 and Controls—A Prospective Cohort Study
A second update on mapping the human genetic architecture of COVID-19 | Nature
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies | PNAS
Covid-19 : des patients manquent d'oxygène sans le savoir - Sciences et Avenir
Frontiers | Divergent adaptive immune responses define two types of long COVID
Frontiers | Hypertonic Solution in Severe COVID-19 Patient: A Potential Adjuvant Therapy
Les malades du Covid-19 vont pouvoir suivre leur taux d'oxygène à la maison - France Bleu
